Nuvation Bio IncNYSE:NUVB
- LAST PRICE3.0500
- TODAY'S CHANGE (%)0.0200 (0.6601%)
- Bid / Lots2.8200/ 3
- Ask / Lots3.0900/ 5
- Open / Previous Close3.0400 / 3.0300
- Day Range
- 52 Week Range
- Volume3,327,973
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVB |
|---|---|---|
| 09:32 ET | 225977 | 3.04 |
| 09:34 ET | 1715 | 3.04 |
| 09:36 ET | 300 | 3.0399 |
| 09:38 ET | 20546 | 2.99 |
| 09:39 ET | 6199 | 2.99 |
| 09:41 ET | 4135 | 3 |
| 09:43 ET | 1540 | 3.01 |
| 09:45 ET | 7587 | 2.97 |
| 09:48 ET | 2042 | 2.985 |
| 09:50 ET | 595 | 2.995 |
| 09:52 ET | 2092 | 2.99 |
| 09:54 ET | 11234 | 2.985 |
| 09:56 ET | 6199 | 2.99 |
| 09:57 ET | 10991 | 2.9799 |
| 09:59 ET | 748 | 2.975 |
| 10:01 ET | 8344 | 2.995 |
| 10:03 ET | 12559 | 2.98 |
| 10:06 ET | 1435 | 2.98 |
| 10:08 ET | 400 | 2.99 |
| 10:10 ET | 124 | 2.985 |
| 10:12 ET | 1698 | 2.985 |
| 10:14 ET | 1855 | 2.99 |
| 10:15 ET | 226 | 2.99 |
| 10:17 ET | 9205 | 3.005 |
| 10:19 ET | 13469 | 3.015 |
| 10:21 ET | 7535 | 3.005 |
| 10:24 ET | 16884 | 2.995 |
| 10:26 ET | 2612 | 3 |
| 10:28 ET | 1913 | 3.02 |
| 10:30 ET | 1260 | 3.015 |
| 10:32 ET | 1733 | 3.004 |
| 10:33 ET | 100 | 3.005 |
| 10:35 ET | 2242 | 3.015 |
| 10:37 ET | 100 | 3.015 |
| 10:39 ET | 300 | 3.015 |
| 10:42 ET | 2512 | 3.005 |
| 10:44 ET | 300 | 3.005 |
| 10:46 ET | 19849 | 3.005 |
| 10:48 ET | 4019 | 3.015 |
| 10:51 ET | 3593 | 3.025 |
| 10:53 ET | 3342 | 3.04 |
| 10:55 ET | 311 | 3.035 |
| 10:57 ET | 800 | 3.035 |
| 11:00 ET | 4698 | 3.025 |
| 11:02 ET | 2826 | 3.025 |
| 11:04 ET | 400 | 3.025 |
| 11:06 ET | 300 | 3.02 |
| 11:08 ET | 100 | 3.02 |
| 11:09 ET | 7406 | 3.005 |
| 11:11 ET | 300 | 3.005 |
| 11:13 ET | 400 | 3.005 |
| 11:15 ET | 500 | 3.01 |
| 11:18 ET | 7190 | 3.01 |
| 11:20 ET | 200 | 3.015 |
| 11:22 ET | 700 | 3.02 |
| 11:24 ET | 100 | 3.01 |
| 11:26 ET | 489 | 3.015 |
| 11:27 ET | 5768 | 2.9908 |
| 11:29 ET | 300 | 3 |
| 11:31 ET | 1703 | 2.995 |
| 11:33 ET | 6712 | 2.981 |
| 11:36 ET | 8782 | 3 |
| 11:40 ET | 398 | 3.005 |
| 11:42 ET | 1047 | 3.005 |
| 11:44 ET | 200 | 3.005 |
| 11:45 ET | 100 | 3 |
| 11:47 ET | 1557 | 3.005 |
| 11:49 ET | 788 | 3.005 |
| 11:51 ET | 348 | 3 |
| 11:54 ET | 100 | 3 |
| 11:56 ET | 100 | 3 |
| 11:58 ET | 1071 | 3 |
| 12:02 ET | 300 | 3.005 |
| 12:03 ET | 412 | 3.005 |
| 12:05 ET | 300 | 3.01 |
| 12:07 ET | 485 | 3 |
| 12:09 ET | 10146 | 2.995 |
| 12:12 ET | 300 | 2.992 |
| 12:14 ET | 300 | 2.99 |
| 12:16 ET | 500 | 2.995 |
| 12:18 ET | 10276 | 3 |
| 12:21 ET | 498 | 3.005 |
| 12:23 ET | 255 | 3.005 |
| 12:25 ET | 100 | 3.01 |
| 12:27 ET | 200 | 3.01 |
| 12:30 ET | 200 | 3.01 |
| 12:32 ET | 300 | 3.005 |
| 12:34 ET | 300 | 3.005 |
| 12:36 ET | 200 | 3.005 |
| 12:38 ET | 200 | 3.005 |
| 12:39 ET | 400 | 3.001 |
| 12:43 ET | 1325 | 3 |
| 12:45 ET | 200 | 3.002 |
| 12:48 ET | 9838 | 2.995 |
| 12:50 ET | 115 | 2.9964 |
| 12:52 ET | 296 | 2.995 |
| 12:54 ET | 11628 | 3 |
| 12:56 ET | 700 | 3.005 |
| 12:57 ET | 100 | 3.01 |
| 12:59 ET | 300 | 3.005 |
| 01:01 ET | 1200 | 3.01 |
| 01:03 ET | 48253 | 2.99 |
| 01:06 ET | 1169 | 2.995 |
| 01:08 ET | 8614 | 2.995 |
| 01:10 ET | 319 | 2.995 |
| 01:12 ET | 300 | 3 |
| 01:14 ET | 600 | 3 |
| 01:17 ET | 412 | 3 |
| 01:19 ET | 1500 | 2.99 |
| 01:21 ET | 900 | 2.995 |
| 01:24 ET | 400 | 2.99 |
| 01:26 ET | 400 | 2.992 |
| 01:28 ET | 200 | 3 |
| 01:30 ET | 2428 | 3 |
| 01:32 ET | 764 | 2.995 |
| 01:33 ET | 1927 | 2.995 |
| 01:35 ET | 816 | 2.995 |
| 01:37 ET | 100 | 2.995 |
| 01:39 ET | 3776 | 2.995 |
| 01:42 ET | 364 | 2.995 |
| 01:44 ET | 678 | 3 |
| 01:46 ET | 379 | 3 |
| 01:50 ET | 400 | 2.995 |
| 01:51 ET | 100 | 2.995 |
| 01:53 ET | 100 | 3 |
| 01:55 ET | 200 | 3 |
| 01:57 ET | 100 | 3 |
| 02:00 ET | 10683 | 3.005 |
| 02:02 ET | 1344 | 3 |
| 02:04 ET | 400 | 3 |
| 02:06 ET | 18850 | 3.015 |
| 02:08 ET | 154 | 3.015 |
| 02:09 ET | 23367 | 3.05 |
| 02:11 ET | 1128 | 3.04 |
| 02:13 ET | 300 | 3.045 |
| 02:15 ET | 300 | 3.045 |
| 02:18 ET | 900 | 3.045 |
| 02:20 ET | 2958 | 3.03 |
| 02:22 ET | 200 | 3.035 |
| 02:24 ET | 1660 | 3.03 |
| 02:26 ET | 100 | 3.035 |
| 02:27 ET | 500 | 3.03 |
| 02:29 ET | 400 | 3.03 |
| 02:31 ET | 400 | 3.035 |
| 02:33 ET | 300 | 3.035 |
| 02:36 ET | 15851 | 3.045 |
| 02:38 ET | 5788 | 3.03 |
| 02:40 ET | 200 | 3.03 |
| 02:42 ET | 100 | 3.035 |
| 02:44 ET | 412 | 3.03 |
| 02:45 ET | 5736 | 3.04 |
| 02:47 ET | 1417 | 3.04 |
| 02:49 ET | 1728 | 3.045 |
| 02:51 ET | 1000 | 3.045 |
| 02:54 ET | 1300 | 3.045 |
| 02:56 ET | 1394 | 3.045 |
| 02:58 ET | 2331 | 3.045 |
| 03:00 ET | 3815 | 3.05 |
| 03:02 ET | 1423 | 3.05 |
| 03:03 ET | 945 | 3.05 |
| 03:05 ET | 2473 | 3.045 |
| 03:07 ET | 600 | 3.05 |
| 03:09 ET | 2127 | 3.045 |
| 03:12 ET | 16611 | 3.0325 |
| 03:14 ET | 6758 | 3.045 |
| 03:16 ET | 2207 | 3.05 |
| 03:18 ET | 1270 | 3.05 |
| 03:20 ET | 4923 | 3.05 |
| 03:21 ET | 616 | 3.05 |
| 03:23 ET | 2432 | 3.045 |
| 03:25 ET | 2944 | 3.045 |
| 03:27 ET | 2617 | 3.05 |
| 03:30 ET | 2287 | 3.045 |
| 03:32 ET | 21964 | 3.045 |
| 03:34 ET | 11355 | 3.03 |
| 03:36 ET | 1038 | 3.035 |
| 03:38 ET | 1844 | 3.035 |
| 03:39 ET | 11969 | 3.05 |
| 03:41 ET | 1288 | 3.045 |
| 03:43 ET | 3347 | 3.045 |
| 03:45 ET | 5346 | 3.04 |
| 03:48 ET | 13452 | 3.04 |
| 03:50 ET | 42886 | 3.04 |
| 03:52 ET | 30950 | 3.06 |
| 03:54 ET | 4909 | 3.055 |
| 03:56 ET | 21323 | 3.065 |
| 03:57 ET | 11249 | 3.05 |
| 03:59 ET | 1593822 | 3.05 |
Jun 3, 2024
DJ Nuvation Bio Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 6:46AM ET on Monday Jun 03, 2024 by Dow Jones
6:46AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting, from 8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
May 29, 2024
Nuvation Bio to Present at the Jefferies Global Healthcare Conference, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones
4:05PM ET on Wednesday May 29, 2024 by Dow Jones
May 24, 2024
DJ Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush, from 10:02AM ET on Friday May 24, 2024 by Dow Jones
10:02AM ET on Friday May 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvation Bio Inc | 753.9M | -9.7x | --- |
Dianthus Therapeutics Inc | 749.3M | -8.0x | --- |
Prime Medicine Inc | 719.0M | -2.8x | --- |
ARS Pharmaceuticals Inc | 791.6M | -15.7x | --- |
ProKidney Corp | 707.8M | -4.4x | --- |
Viridian Therapeutics Inc | 802.2M | -2.8x | --- |
Company Information
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Contact Information
- Headquarters
- 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
- Phone
- 415-754-3517
- Fax
- 302-636-5454
Executives
- Independent Chair of the Board
- Daniel Welch
- President, Chief Executive Officer, Founder, Director
- David Hung
- Principal Financial and Accounting Officer, Vice President - Finance
- Moses Makunje
- Chief Executive Officer of AnHeart Therapeutics and Director
- Junyuan Wang
- Chief People Officer
- Stacy Markel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $753.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.41 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -9.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
